Anaesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine With Symptomatic Irreversible Pulpitis

• Status: Completed
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this randomized, double-blinded, clinical trial was to assess the effect of 3.6 mL 2% mepivacaine hydrochloride with 1:100,000 epinephrine compared to 3.4 mL 4% articaine hydrochloride with 1:100,000 epinephrine on the success of the inferior alveolar nerve block for patients with symptomatic irreversible pulpitis in mandibular molars.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Carticaine; Mepivacaine

Criteria

Inclusion Criteria:

• Patients in good health (American Society of Anesthesiologists Class I or II).

• Patients having symptomatic irreversible pulpitis in one of their mandibular molars.

• Age range between 18 to 50 years.

• Patients who can understand Numerical Rating Scale (NRS).

• Positive patient acceptance and the ability to sign an informed consent.

Exclusion Criteria:

• Pregnant females.

• Patients allergic to articaine, mepivacaine and/or any used medication or material.

• Patients having active sites of pathosis in the area of injection.

• Patients having active pain in more than one molar.

• Patients who had taken analgesics in the 12 hours preceding treatment.